Loring Wolcott & Coolidge Fiduciary Advisors LLP Voyager Therapeutics, Inc. Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

$11.1 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2019 Jan 22, 2020	SELL	$12.82 - $16.85 $26,922 - $35,385	-2,100 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$12.26 - $25.88 $25,746 - $54,348	2,100	2,100 $35,000

Others Institutions Holding VYGR

# of Institutions

130

Shares Held

34.7M

Call Options Held

39.7K

Put Options Held

34.6K

Black Rock Inc. New York, NY

5.31M
Shares

$31.7 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

5.2M
Shares

$31 Million
0.5% of portfolio
Eco R1 Capital, LLC San Francisco, CA

3.92M
Shares

$23.4 Million
0.99% of portfolio
Vanguard Group Inc Valley Forge, PA

3.19M
Shares

$19 Million
0.0% of portfolio
Farallon Capital Management LLC San Francisco, CA

2.29M
Shares

$13.7 Million
0.07% of portfolio

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $231M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Account